company background image
1099 logo

Sinopharm Group SEHK:1099 Stok Raporu

Son Fiyat

HK$21.95

Piyasa Değeri

HK$64.9b

7D

20.6%

1Y

0.2%

Güncellenmiş

02 Oct, 2024

Veri

Şirket Finansalları +

Sinopharm Group Co. Ltd.

SEHK:1099 Stok Raporu

Piyasa değeri: HK$64.9b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

1099 Stoklara Genel Bakış

Sinopharm Group Co. Ltd. iştirakleri ile birlikte Çin Halk Cumhuriyeti'nde ilaç, tıbbi cihaz ve sağlık ürünlerinin toptan ve perakende satışını yapmaktadır.

Şirket hakkında

Ödüller

Adil değer tahminimizden 41.8% daha düşük bir oranda işlem görüyor
Kazançların yılda 5.88% oranında artması öngörülüyor
4.34% oranında güvenilir bir temettü öder
Rakiplerine ve sektöre kıyasla iyi değerde işlem görüyor

Risk Analizi

Yüksek borç seviyesine sahip

Sinopharm Group Co. Ltd. Rakipler

Guangzhou Baiyunshan Pharmaceutical Holdings

SEHK:874

HK$52.2b

IVD Medical Holding

SEHK:1931

HK$3.6b

Tycoon Group Holdings

SEHK:3390

HK$3.0b

Shanghai Pioneer Holding

SEHK:1345

HK$2.4b

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Sinopharm Group
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıHK$21.95
52 Haftanın En Yüksek SeviyesiHK$23.00
52 Haftanın En Düşük SeviyesiHK$16.02
Beta0.88
11 Aylık Değişim22.63%
3 Aylık Değişim6.04%
1 Yıllık Değişim0.23%
33 Yıllık Değişim9.48%
5 Yıllık Değişim-12.72%
Halka arzdan bu yana değişim18.52%

Son Haberler & Güncellemeler

Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

Aug 23
Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

Recent updates

Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

Aug 23
Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

The Market Doesn't Like What It Sees From Sinopharm Group Co. Ltd.'s (HKG:1099) Earnings Yet

Jul 27
The Market Doesn't Like What It Sees From Sinopharm Group Co. Ltd.'s (HKG:1099) Earnings Yet

Sinopharm Group (HKG:1099) Is Increasing Its Dividend To CN¥0.956

Jun 16
Sinopharm Group (HKG:1099) Is Increasing Its Dividend To CN¥0.956

Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 46% Discount?

May 13
Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 46% Discount?

Is Sinopharm Group (HKG:1099) A Risky Investment?

Apr 22
Is Sinopharm Group (HKG:1099) A Risky Investment?

Investors Could Be Concerned With Sinopharm Group's (HKG:1099) Returns On Capital

Mar 21
Investors Could Be Concerned With Sinopharm Group's (HKG:1099) Returns On Capital

Should You Think About Buying Sinopharm Group Co. Ltd. (HKG:1099) Now?

Mar 06
Should You Think About Buying Sinopharm Group Co. Ltd. (HKG:1099) Now?

Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 29% Discount?

Jan 31
Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 29% Discount?

Is Sinopharm Group (HKG:1099) A Risky Investment?

Jan 15
Is Sinopharm Group (HKG:1099) A Risky Investment?

There Is A Reason Sinopharm Group Co. Ltd.'s (HKG:1099) Price Is Undemanding

Dec 31
There Is A Reason Sinopharm Group Co. Ltd.'s (HKG:1099) Price Is Undemanding

Returns On Capital Signal Tricky Times Ahead For Sinopharm Group (HKG:1099)

Nov 29
Returns On Capital Signal Tricky Times Ahead For Sinopharm Group (HKG:1099)

If EPS Growth Is Important To You, Sinopharm Group (HKG:1099) Presents An Opportunity

Nov 14
If EPS Growth Is Important To You, Sinopharm Group (HKG:1099) Presents An Opportunity

Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 28% Discount?

Nov 01
Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 28% Discount?

Should You Investigate Sinopharm Group Co. Ltd. (HKG:1099) At HK$22.45?

Sep 20
Should You Investigate Sinopharm Group Co. Ltd. (HKG:1099) At HK$22.45?

Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Sep 05
Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

Aug 18
Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

Are Sinopharm Group Co. Ltd. (HKG:1099) Investors Paying Above The Intrinsic Value?

Aug 02
Are Sinopharm Group Co. Ltd. (HKG:1099) Investors Paying Above The Intrinsic Value?

Sinopharm Group (HKG:1099) Seems To Use Debt Quite Sensibly

Jun 01
Sinopharm Group (HKG:1099) Seems To Use Debt Quite Sensibly

Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

Apr 26
Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

Feb 27
These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

Sinopharm Group (HKG:1099) Has Some Way To Go To Become A Multi-Bagger

Jan 19
Sinopharm Group (HKG:1099) Has Some Way To Go To Become A Multi-Bagger

Is Sinopharm Group (HKG:1099) A Risky Investment?

Nov 18
Is Sinopharm Group (HKG:1099) A Risky Investment?

Returns At Sinopharm Group (HKG:1099) Appear To Be Weighed Down

Oct 03
Returns At Sinopharm Group (HKG:1099) Appear To Be Weighed Down

Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Jul 31
Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Estimating The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Jul 10
Estimating The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Slowing Rates Of Return At Sinopharm Group (HKG:1099) Leave Little Room For Excitement

Jun 05
Slowing Rates Of Return At Sinopharm Group (HKG:1099) Leave Little Room For Excitement

We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt

Apr 11
We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt

A Look At The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Mar 21
A Look At The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Sinopharm Group (HKG:1099) Hasn't Managed To Accelerate Its Returns

Mar 03
Sinopharm Group (HKG:1099) Hasn't Managed To Accelerate Its Returns

Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Jan 09
Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Sinopharm Group Co., Ltd.'s (HKG:1099) Intrinsic Value Is Potentially 28% Above Its Share Price

Dec 19
Sinopharm Group Co., Ltd.'s (HKG:1099) Intrinsic Value Is Potentially 28% Above Its Share Price

Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

Dec 01
Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

Sep 23
These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

A Look At The Fair Value Of Sinopharm Group Co., Ltd. (HKG:1099)

Sep 10
A Look At The Fair Value Of Sinopharm Group Co., Ltd. (HKG:1099)

Return Trends At Sinopharm Group (HKG:1099) Aren't Appealing

Aug 28
Return Trends At Sinopharm Group (HKG:1099) Aren't Appealing

Sinopharm Group (HKG:1099) Is Increasing Its Dividend To HK$0.84

Jun 13
Sinopharm Group (HKG:1099) Is Increasing Its Dividend To HK$0.84

Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

Jun 06
Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

Is Sinopharm Group Co., Ltd. (HKG:1099) Expensive For A Reason? A Look At Its Intrinsic Value

May 24
Is Sinopharm Group Co., Ltd. (HKG:1099) Expensive For A Reason? A Look At Its Intrinsic Value

Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

May 11
Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

Have Insiders Been Selling Sinopharm Group Co., Ltd. (HKG:1099) Shares?

Mar 20
Have Insiders Been Selling Sinopharm Group Co., Ltd. (HKG:1099) Shares?

We Think Sinopharm Group (HKG:1099) Is Taking Some Risk With Its Debt

Mar 05
We Think Sinopharm Group (HKG:1099) Is Taking Some Risk With Its Debt

You Have To Love Sinopharm Group Co., Ltd.'s (HKG:1099) Dividend

Feb 18
You Have To Love Sinopharm Group Co., Ltd.'s (HKG:1099) Dividend

Should You Be Impressed By Sinopharm Group's (HKG:1099) Returns on Capital?

Feb 03
Should You Be Impressed By Sinopharm Group's (HKG:1099) Returns on Capital?

Hissedar Getirileri

1099HK HealthcareHK Pazar
7D20.6%16.1%8.7%
1Y0.2%-21.9%19.7%

Getiri vs. Endüstri: 1099 geçen yıl % -21.9 oranında getiri sağlayan Hong Kong Healthcare sektörünü aştı.

Getiri vs Piyasa: 1099 geçen yıl % 19.7 oranında getiri sağlayan Hong Kong Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is 1099's price volatile compared to industry and market?
1099 volatility
1099 Average Weekly Movement4.3%
Healthcare Industry Average Movement6.7%
Market Average Movement7.1%
10% most volatile stocks in HK Market14.7%
10% least volatile stocks in HK Market3.6%

İstikrarlı Hisse Senedi Fiyatı: 1099 hisse senedi fiyatı son 3 aydır dalgalı bir seyir izliyor.

Zaman İçindeki Volatilite: 1099 'nin haftalık oynaklığı ( 4% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
2003113,635Wanyong Lianwww.sinopharmgroup.com.cn

Sinopharm Group Co. Ltd. iştirakleri ile birlikte Çin Halk Cumhuriyeti'nde ilaç, tıbbi cihaz ve sağlık ürünlerinin toptan ve perakende satışını yapmaktadır. Şirket dört segmentte faaliyet göstermektedir: İlaç Dağıtımı, Tıbbi Cihazlar, Perakende Eczane ve Diğer İşler. İlaç Dağıtımı segmenti, farmasötik ürünleri hastanelere, diğer distribütörlere, perakende eczane mağazalarına ve kliniklere dağıtmaktadır.

Sinopharm Group Co. Ltd. Temel Bilgiler Özeti

Sinopharm Group'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
1099 temel i̇stati̇sti̇kler
Piyasa değeriHK$64.91b
Kazançlar(TTM)HK$9.56b
Gelir(TTM)HK$652.05b

7.2x

F/K Oranı

0.1x

P/S Oranı

1099 aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
1099 gelir tablosu (TTM)
GelirCN¥590.35b
Gelir MaliyetiCN¥543.16b
Brüt KârCN¥47.18b
Diğer GiderlerCN¥38.53b
KazançlarCN¥8.65b

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)2.77
Brüt Marj7.99%
Net Kâr Marjı1.47%
Borç/Özkaynak Oranı78.1%

1099 uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

4.3%

Mevcut Temettü Verimi

31%

Ödeme Oranı